Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT4219 | Individual Protein | Choline acetylase | Homo sapiens | Ki | = | 75000 | nM | 7310833 |
NPT2 | Others | Unspecified | IC50 | = | 68580 | nM | 19114310 | |
NPT4248 | Individual Protein | Histone acetyltransferase KAT5 | Homo sapiens | IC50 | = | 82270 | nM | 19114310 |
NPT1079 | Individual Protein | Histone acetyltransferase p300 | Homo sapiens | IC50 | = | 45940 | nM | 19114310 |
NPT1080 | Individual Protein | Histone acetyltransferase PCAF | Homo sapiens | IC50 | = | 41910 | nM | 19114310 |
NPT2 | Others | Unspecified | FC | = | 10 | 19182784 | ||
NPT2 | Others | Unspecified | Ki | = | 1480 | nM | 19182784 | |
NPT2 | Others | Unspecified | IC50 | = | 1200 | nM | 19182784 | |
NPT2 | Others | Unspecified | Ki | = | 4900 | nM | 19182784 | |
NPT2 | Others | Unspecified | IC50 | = | 1250 | nM | 19182784 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC189261 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8987 | High Similarity | NPC226245 |
0.8981 | High Similarity | NPC174802 |
0.8917 | High Similarity | NPC130586 |
0.8917 | High Similarity | NPC164952 |
0.879 | High Similarity | NPC85689 |
0.879 | High Similarity | NPC185991 |
0.879 | High Similarity | NPC211025 |
0.879 | High Similarity | NPC161224 |
0.875 | High Similarity | NPC316618 |
0.8734 | High Similarity | NPC321814 |
0.8679 | High Similarity | NPC302778 |
0.8679 | High Similarity | NPC212551 |
0.8599 | High Similarity | NPC121222 |
0.8598 | High Similarity | NPC323091 |
0.8571 | High Similarity | NPC224076 |
0.8471 | Intermediate Similarity | NPC189068 |
0.8418 | Intermediate Similarity | NPC309832 |
0.8418 | Intermediate Similarity | NPC219313 |
0.8412 | Intermediate Similarity | NPC326529 |
0.8408 | Intermediate Similarity | NPC107374 |
0.8408 | Intermediate Similarity | NPC21448 |
0.8408 | Intermediate Similarity | NPC156461 |
0.8363 | Intermediate Similarity | NPC319100 |
0.8363 | Intermediate Similarity | NPC324198 |
0.8354 | Intermediate Similarity | NPC164665 |
0.8313 | Intermediate Similarity | NPC136349 |
0.8302 | Intermediate Similarity | NPC269827 |
0.828 | Intermediate Similarity | NPC229974 |
0.8225 | Intermediate Similarity | NPC324033 |
0.8225 | Intermediate Similarity | NPC321458 |
0.8182 | Intermediate Similarity | NPC239737 |
0.8176 | Intermediate Similarity | NPC326082 |
0.8166 | Intermediate Similarity | NPC261595 |
0.816 | Intermediate Similarity | NPC328479 |
0.816 | Intermediate Similarity | NPC472816 |
0.8153 | Intermediate Similarity | NPC209525 |
0.8153 | Intermediate Similarity | NPC317821 |
0.8153 | Intermediate Similarity | NPC161659 |
0.8133 | Intermediate Similarity | NPC195140 |
0.805 | Intermediate Similarity | NPC314152 |
0.7975 | Intermediate Similarity | NPC129756 |
0.7939 | Intermediate Similarity | NPC207633 |
0.7849 | Intermediate Similarity | NPC325906 |
0.7791 | Intermediate Similarity | NPC324484 |
0.7751 | Intermediate Similarity | NPC54320 |
0.7751 | Intermediate Similarity | NPC313754 |
0.7751 | Intermediate Similarity | NPC311197 |
0.7711 | Intermediate Similarity | NPC150853 |
0.7692 | Intermediate Similarity | NPC52238 |
0.7688 | Intermediate Similarity | NPC33996 |
0.7688 | Intermediate Similarity | NPC30326 |
0.7683 | Intermediate Similarity | NPC232408 |
0.7683 | Intermediate Similarity | NPC64705 |
0.7622 | Intermediate Similarity | NPC317746 |
0.7622 | Intermediate Similarity | NPC177169 |
0.7584 | Intermediate Similarity | NPC313897 |
0.7562 | Intermediate Similarity | NPC320818 |
0.7561 | Intermediate Similarity | NPC318590 |
0.7561 | Intermediate Similarity | NPC251233 |
0.7561 | Intermediate Similarity | NPC211820 |
0.7515 | Intermediate Similarity | NPC89147 |
0.7515 | Intermediate Similarity | NPC274384 |
0.7471 | Intermediate Similarity | NPC14590 |
0.7442 | Intermediate Similarity | NPC93365 |
0.7439 | Intermediate Similarity | NPC186619 |
0.7294 | Intermediate Similarity | NPC326694 |
0.7263 | Intermediate Similarity | NPC290959 |
0.7134 | Intermediate Similarity | NPC61198 |
0.7112 | Intermediate Similarity | NPC24589 |
0.709 | Intermediate Similarity | NPC282458 |
0.709 | Intermediate Similarity | NPC78941 |
0.7073 | Intermediate Similarity | NPC262926 |
0.7011 | Intermediate Similarity | NPC321052 |
0.7 | Intermediate Similarity | NPC313514 |
0.6909 | Remote Similarity | NPC319221 |
0.6887 | Remote Similarity | NPC107160 |
0.6882 | Remote Similarity | NPC74306 |
0.6882 | Remote Similarity | NPC315642 |
0.6848 | Remote Similarity | NPC324009 |
0.6774 | Remote Similarity | NPC158055 |
0.675 | Remote Similarity | NPC276373 |
0.6739 | Remote Similarity | NPC168702 |
0.6739 | Remote Similarity | NPC125659 |
0.6716 | Remote Similarity | NPC5802 |
0.6685 | Remote Similarity | NPC33382 |
0.6683 | Remote Similarity | NPC157821 |
0.6636 | Remote Similarity | NPC21461 |
0.6578 | Remote Similarity | NPC222174 |
0.6527 | Remote Similarity | NPC104011 |
0.6378 | Remote Similarity | NPC321393 |
0.6326 | Remote Similarity | NPC250178 |
0.6284 | Remote Similarity | NPC472834 |
0.622 | Remote Similarity | NPC327579 |
0.6188 | Remote Similarity | NPC160666 |
0.6163 | Remote Similarity | NPC57279 |
0.6036 | Remote Similarity | NPC248007 |
0.602 | Remote Similarity | NPC164845 |
0.6013 | Remote Similarity | NPC476564 |
0.6 | Remote Similarity | NPC217656 |
0.5972 | Remote Similarity | NPC103388 |
0.5967 | Remote Similarity | NPC89139 |
0.5955 | Remote Similarity | NPC296437 |
0.5954 | Remote Similarity | NPC246193 |
0.5924 | Remote Similarity | NPC174114 |
0.5924 | Remote Similarity | NPC87981 |
0.5922 | Remote Similarity | NPC470266 |
0.587 | Remote Similarity | NPC244700 |
0.5858 | Remote Similarity | NPC139776 |
0.5856 | Remote Similarity | NPC476433 |
0.5856 | Remote Similarity | NPC476528 |
0.585 | Remote Similarity | NPC473585 |
0.5847 | Remote Similarity | NPC314774 |
0.5847 | Remote Similarity | NPC324815 |
0.5847 | Remote Similarity | NPC315126 |
0.5824 | Remote Similarity | NPC476013 |
0.5824 | Remote Similarity | NPC476520 |
0.5824 | Remote Similarity | NPC476522 |
0.5824 | Remote Similarity | NPC474986 |
0.582 | Remote Similarity | NPC472833 |
0.5815 | Remote Similarity | NPC476408 |
0.5813 | Remote Similarity | NPC265111 |
0.5792 | Remote Similarity | NPC476521 |
0.5771 | Remote Similarity | NPC287876 |
0.5732 | Remote Similarity | NPC312187 |
0.5732 | Remote Similarity | NPC4837 |
0.5729 | Remote Similarity | NPC472832 |
0.5729 | Remote Similarity | NPC18308 |
0.5714 | Remote Similarity | NPC14330 |
0.5646 | Remote Similarity | NPC313504 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC189261 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9398 | High Similarity | NPD6417 | Clinical (unspecified phase) |
0.8981 | High Similarity | NPD339 | Approved |
0.8917 | High Similarity | NPD338 | Approved |
0.879 | High Similarity | NPD283 | Approved |
0.875 | High Similarity | NPD1412 | Clinical (unspecified phase) |
0.8679 | High Similarity | NPD242 | Approved |
0.8571 | High Similarity | NPD169 | Phase 2 |
0.8409 | Intermediate Similarity | NPD2632 | Approved |
0.8409 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.8409 | Intermediate Similarity | NPD2630 | Approved |
0.8408 | Intermediate Similarity | NPD250 | Approved |
0.8408 | Intermediate Similarity | NPD249 | Approved |
0.8405 | Intermediate Similarity | NPD2624 | Phase 2 |
0.8383 | Intermediate Similarity | NPD7988 | Suspended |
0.8363 | Intermediate Similarity | NPD4171 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD3107 | Discontinued |
0.8313 | Intermediate Similarity | NPD548 | Clinical (unspecified phase) |
0.8302 | Intermediate Similarity | NPD195 | Approved |
0.8302 | Intermediate Similarity | NPD186 | Discovery |
0.8276 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.8218 | Intermediate Similarity | NPD4716 | Approved |
0.8204 | Intermediate Similarity | NPD3083 | Approved |
0.8182 | Intermediate Similarity | NPD2646 | Discontinued |
0.8166 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.811 | Intermediate Similarity | NPD1750 | Clinical (unspecified phase) |
0.811 | Intermediate Similarity | NPD1369 | Phase 2 |
0.805 | Intermediate Similarity | NPD185 | Approved |
0.8012 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7989 | Intermediate Similarity | NPD5666 | Phase 2 |
0.7964 | Intermediate Similarity | NPD1732 | Phase 3 |
0.795 | Intermediate Similarity | NPD166 | Approved |
0.7925 | Intermediate Similarity | NPD193 | Suspended |
0.7849 | Intermediate Similarity | NPD1776 | Approved |
0.7849 | Intermediate Similarity | NPD1777 | Approved |
0.7751 | Intermediate Similarity | NPD216 | Approved |
0.7751 | Intermediate Similarity | NPD218 | Approved |
0.7751 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.7751 | Intermediate Similarity | NPD217 | Approved |
0.7751 | Intermediate Similarity | NPD219 | Phase 3 |
0.7622 | Intermediate Similarity | NPD7158 | Phase 1 |
0.7596 | Intermediate Similarity | NPD5682 | Phase 3 |
0.7596 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.7596 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.7574 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.7574 | Intermediate Similarity | NPD214 | Approved |
0.7442 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.7399 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.7396 | Intermediate Similarity | NPD3085 | Phase 1 |
0.738 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7353 | Intermediate Similarity | NPD3086 | Phase 3 |
0.7297 | Intermediate Similarity | NPD1692 | Approved |
0.7296 | Intermediate Similarity | NPD9633 | Phase 3 |
0.725 | Intermediate Similarity | NPD248 | Discontinued |
0.725 | Intermediate Similarity | NPD9632 | Phase 3 |
0.7169 | Intermediate Similarity | NPD3695 | Approved |
0.7169 | Intermediate Similarity | NPD3696 | Approved |
0.7143 | Intermediate Similarity | NPD4240 | Approved |
0.7134 | Intermediate Similarity | NPD252 | Clinical (unspecified phase) |
0.7125 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.7107 | Intermediate Similarity | NPD9408 | Phase 3 |
0.7066 | Intermediate Similarity | NPD549 | Approved |
0.7022 | Intermediate Similarity | NPD516 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD7138 | Phase 2 |
0.695 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.695 | Remote Similarity | NPD2876 | Phase 3 |
0.6882 | Remote Similarity | NPD582 | Approved |
0.6881 | Remote Similarity | NPD2824 | Phase 2 |
0.6867 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.6859 | Remote Similarity | NPD1063 | Phase 2 |
0.6857 | Remote Similarity | NPD353 | Discontinued |
0.6818 | Remote Similarity | NPD536 | Clinical (unspecified phase) |
0.6816 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD3708 | Phase 2 |
0.6779 | Remote Similarity | NPD5080 | Phase 2 |
0.6774 | Remote Similarity | NPD6840 | Approved |
0.6731 | Remote Similarity | NPD5079 | Phase 2 |
0.665 | Remote Similarity | NPD4495 | Phase 1 |
0.6573 | Remote Similarity | NPD6381 | Phase 2 |
0.6545 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6514 | Remote Similarity | NPD171 | Discontinued |
0.6507 | Remote Similarity | NPD2902 | Phase 2 |
0.6507 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.645 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6444 | Remote Similarity | NPD231 | Clinical (unspecified phase) |
0.6354 | Remote Similarity | NPD9605 | Phase 3 |
0.6316 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6258 | Remote Similarity | NPD9606 | Approved |
0.622 | Remote Similarity | NPD9607 | Approved |
0.6201 | Remote Similarity | NPD1730 | Discontinued |
0.62 | Remote Similarity | NPD207 | Discontinued |
0.62 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6163 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6158 | Remote Similarity | NPD2253 | Discontinued |
0.6158 | Remote Similarity | NPD1430 | Approved |
0.6158 | Remote Similarity | NPD1431 | Approved |
0.6138 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6121 | Remote Similarity | NPD307 | Approved |
0.6106 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.6085 | Remote Similarity | NPD5768 | Phase 2 |
0.6084 | Remote Similarity | NPD9409 | Discontinued |
0.6044 | Remote Similarity | NPD775 | Approved |
0.6036 | Remote Similarity | NPD9084 | Phase 2 |
0.6034 | Remote Similarity | NPD1058 | Discontinued |
0.6 | Remote Similarity | NPD1119 | Phase 2 |
0.5989 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.5989 | Remote Similarity | NPD1808 | Phase 1 |
0.5983 | Remote Similarity | NPD8250 | Phase 2 |
0.5976 | Remote Similarity | NPD9374 | Approved |
0.5952 | Remote Similarity | NPD4458 | Phase 2 |
0.5952 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.5951 | Remote Similarity | NPD9373 | Approved |
0.5947 | Remote Similarity | NPD5627 | Approved |
0.5943 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.592 | Remote Similarity | NPD282 | Approved |
0.5876 | Remote Similarity | NPD1120 | Approved |
0.5876 | Remote Similarity | NPD1121 | Approved |
0.5874 | Remote Similarity | NPD6036 | Suspended |
0.586 | Remote Similarity | NPD7842 | Phase 2 |
0.5849 | Remote Similarity | NPD5486 | Discontinued |
0.5833 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.5823 | Remote Similarity | NPD5171 | Clinical (unspecified phase) |
0.5813 | Remote Similarity | NPD6023 | Discontinued |
0.581 | Remote Similarity | NPD799 | Phase 1 |
0.5771 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.5767 | Remote Similarity | NPD5458 | Discontinued |
0.5754 | Remote Similarity | NPD6112 | Approved |
0.5747 | Remote Similarity | NPD1128 | Approved |
0.5747 | Remote Similarity | NPD1127 | Approved |
0.5746 | Remote Similarity | NPD1118 | Discontinued |
0.5708 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.569 | Remote Similarity | NPD515 | Phase 1 |
0.5684 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.5683 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5674 | Remote Similarity | NPD4715 | Clinical (unspecified phase) |
0.5674 | Remote Similarity | NPD4713 | Clinical (unspecified phase) |
0.5674 | Remote Similarity | NPD34 | Approved |
0.5674 | Remote Similarity | NPD4714 | Approved |
0.5668 | Remote Similarity | NPD2452 | Phase 2 |
0.5668 | Remote Similarity | NPD2453 | Phase 2 |
0.5668 | Remote Similarity | NPD2451 | Phase 2 |
0.5668 | Remote Similarity | NPD2450 | Phase 2 |
0.5652 | Remote Similarity | NPD5342 | Clinical (unspecified phase) |
0.5642 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.5632 | Remote Similarity | NPD281 | Approved |
0.5625 | Remote Similarity | NPD6351 | Discovery |
0.5619 | Remote Similarity | NPD4187 | Clinical (unspecified phase) |
0.5607 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.5607 | Remote Similarity | NPD798 | Discontinued |
0.56 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
PubChem CID   | 87642 |
ChEMBL   | CHEMBL1213327 |
ZINC   |
Molecular Weight:   | 767.12 |
ALogP:   | -2.0044 |
MLogP:   | 0.8 |
XLogP:   | -5.381 |
# Rotatable Bonds:   | 30 |
Polar Surface Area:   | 421.77 |
# H-Bond Aceptor:   | 23 |
# H-Bond Donor:   | 9 |
# Rings:   | 3 |
# Heavy Atoms:   | 48 |